Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Evaxion Biotech A/S ADR (NQ: EVAX ) 2.640 +0.050 (+1.93%) Streaming Delayed Price Updated: 3:34 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Evaxion Biotech A/S ADR < Previous 1 2 3 4 5 6 7 Next > Evaxion announces business update and third quarter 2024 financial results October 31, 2024 From Evaxion Biotech Via GlobeNewswire Evaxion Biotech Partners With Merck To Expand Vaccine Development September 26, 2024 Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates. The deal includes $3.2 million upfront and potential earnings up to $592... Via Benzinga Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing September 20, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Recap: Evaxion Biotech Q4 Earnings March 27, 2024 Via Benzinga Life Sciences Virtual Investor Forum Agenda Announced for September 19th September 16, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q2 2024 August 14, 2024 EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Evaxion Announces Business Update and Second Quarter 2024 Financial Results August 14, 2024 From Evaxion Biotech Via GlobeNewswire iAccess Alpha's Buyside Best Ideas Virtual Summer Conference June 25-26, 2024 June 21, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's After-Market Session June 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 17, 2024 Via Benzinga EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q1 2024 May 28, 2024 EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Evaxion Announces Business Update and First Quarter 2024 Financial Results May 28, 2024 From Evaxion Biotech Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session April 02, 2024 Via Benzinga Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection April 02, 2024 From Evaxion Biotech Via GlobeNewswire EVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023 March 27, 2024 EVAX stock results show that Evaxion Biotech met analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Evaxion Announces Business Update and Full Year 2023 Financial Results March 27, 2024 From Evaxion Biotech Via GlobeNewswire Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform March 19, 2024 From Evaxion Biotech Via GlobeNewswire Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations February 29, 2024 From Evaxion Biotech Via GlobeNewswire Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD February 20, 2024 From Evaxion Biotech Via GlobeNewswire Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement February 07, 2024 From Evaxion Biotech Via GlobeNewswire Evaxion Announces Closing of $15 Million Public Offering February 06, 2024 From Evaxion Biotech Via GlobeNewswire Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 01, 2024 Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. Via Benzinga Evaxion Biotech Announces Pricing of $15 Million Public Offering February 01, 2024 From Evaxion Biotech Via GlobeNewswire Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 31, 2024 Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 25, 2024 Via Benzinga Dow Edges Lower; US Composite PMI Rises In January January 24, 2024 U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today? January 24, 2024 Evaxion Biotech revolutionizes cancer vaccine development, targeting AI-identified ERVs. Preclinical activities underway; Proof-of-Concept data expected by 2H 2024. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
